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LETTER TO THE EDITOR
Derailing individualized ovarian
stimulation
Sir,
We read with interest the paper by Tilborg that incorporated a post
hoc analysis of the utility of anti-müllerian hormone (AMH) for a cost-
effectiveness analysis (van Tilborg et al., 2017). The authors predicated
the randomized control trial (RCT) and individualization of dose solely
on antral follicle count, but there are a number of substantial issues that
question the ability to retrospectively draw conclusions on the utility of
AMH to individualize treatment. Speciﬁcally, longitudinal measurement
of serum AMH shows during GnRH-agonist downregulation shows
marked and clinically relevant changes, an effect dependent on the dur-
ation of GnRH-agonist treatment (Su et al., 2013, Drakopoulos et al.,
2017). Therefore, serum AMH level should be measured before start of
GnRH-agonist downregulation and not once started, as performed by
Tilborg and colleagues. Secondly, four AMH categories have been devel-
oped, but is unclear what modelling underlies these thresholds.
Particularly AMH of 1.33 to <2.25ng/ml (9.5–18.0 pmol/l) was used to
classify normal responders, but in recent phase II (Arce et al., 2014) and
phase III RCTs (Nyboe Andersen et al., 2017), a poor response to ovar-
ian stimulation was anticipated with AMH values <15.0 pmol/l (<2.1
ng/ml) (Arce et al., 2014). Thirdly, retrospectively predicting the out-
come of individualization of treatment based on AMH assumes equiva-
lence with AFC in their association with oocyte yield. In contrast to
older meta-analyses, several recent multicentre studies demonstrate that
AMH exhibits an almost two-fold higher correlation coefﬁcient with
oocyte yield than that observed for AFC determined across multiple
sites (Nelson et al. 2015) and substantially lower variability (Anderson
et al., 2015). The variability between trial sites in AFC (or indeed in
AMH) for the current study is not presented. Lastly, the authors use
statistical methodology to predict the outcome for the 24% of women
where AMH and AFC were discordant. However, this model incorpo-
rates the applied FSH dose which was based on the AFC but not on
AMH, and the assumption that post hoc modelled predictions can
replace real clinical outcomes is questionable. Collectively, these con-
cerns would suggest that, rather than retrospectively infer conclusions
about the utility of AMH for individualizing treatment from incorrectly
timed samples, evidence from a large scale prospective international mul-
ticentre RCT should be used (Nyboe Andersen et al., 2017).
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